O. Mirallas

Updates in CAR-T and TCR-T therapy for solid tumors from the 2026 ASCO Annual Meeting

Adoptive cellular therapies (ACT) have reshaped the treatment landscape of hematologic malignancies and are increasingly being explored in solid tumors. Key approaches include chimeric antigen receptor T-cell (CAR-T) therapy, which targets tumor-associated surface antigens in an HLA-independent manner, and T-cell recep...